The Connected Vehicle Security Act of 2026 restricts the importation, sale, and use of connected vehicles and related technology from China, Russia, Iran, and North Korea to protect national security. Starting in 2027, the bill generally bans these vehicles if they originate from or are controlled by these countries, with separate restrictions on software and hardware taking effect in 2030. The Secretary of Commerce is authorized to issue specific exemptions for items that do not pose a security risk and must publish a list of approved products. The law also requires companies to submit declarations confirming their vehicles comply with the rules and imposes heavy fines for violations.
The Main Street Capital Access Act reduces regulatory burdens for smaller banks, particularly those with less than $10 billion in assets. Key provisions include a 3-year phase-in period for new banks to meet capital requirements, lower leverage ratio requirements for rural banks (7.5% for the first 2 years), and a 30-day review process for business plan deviations. The bill also establishes an Office of Independent Examination Review, sets specific timelines for examinations (270 days) and reports (90 days), and creates a "least cost exception" for bank resolutions to prevent excessive concentration of the banking system. These changes aim to promote new bank formation, improve regulatory efficiency, and support community banking while maintaining financial stability.
The Protection Against Mass Surveillance Act prohibits federal agencies from buying, using, or contracting for automated surveillance systems that rely on license plate recognition, facial recognition, biometric identification, or other technologies designed for mass tracking. It also prevents state, local, and tribal governments from using federal funds to acquire or operate these same surveillance tools. If federal agencies obtain data in violation of these rules, the law requires them to delete the information within 30 days and bars its use as evidence in any court or administrative proceeding.
S 3456, the Law Enforcement Officer and Firefighter Recreation Pass Act, creates a free annual pass for eligible law enforcement officers and firefighters to use at national parks and federal recreational lands. The bill directly affects active officers and firefighters employed by federal, state, local, or tribal governments who perform duties related to crime prevention/detection or fire suppression. It amends existing law to require the Secretary to provide these passes at no cost, after verifying eligibility through proof of employment. The key mechanism is expanding the current pass program to specifically include these public safety professionals under defined roles.
HR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
HR 1266, the Combating Illicit Xylazine Act, adds xylazine - a veterinary sedative increasingly found in illicit drug mixtures - to Schedule III of the Controlled Substances Act, regulating its use and trafficking. It directly affects veterinarians, animal owners, and manufacturers by allowing xylazine to be legally dispensed for animal use under specific veterinary prescriptions, while prohibiting non-veterinary human use. The bill includes transition periods (60 days for practitioners, 1 year for labeling) to ease compliance for manufacturers and practitioners, and requires the DEA and FDA to expedite necessary applications. It also mandates two congressional reports on xylazine's illicit use and trafficking patterns, and directs the Sentencing Commission to review penalties for offenses involving xylazine.
This bill establishes a comprehensive sanctions framework targeting the Russian government and its affiliated entities in response to ongoing military actions. It authorizes the President to block assets, revoke visas, and prohibit financial transactions for Russian officials, military leaders, and foreign persons supporting Russia's defense industry or undermining Ukraine. The legislation also bans U.S. investments in Russian energy sectors, prohibits the purchase of Russian sovereign debt, and imposes high tariffs on Russian imports while restricting crude oil purchases by specific foreign nations. Additionally, the bill prevents Russian companies from listing on U.S. stock exchanges and includes mechanisms for terminating sanctions only if Russia signs a peace agreement accepted by Ukraine and ceases hostilities.
The NO BOSS Act modifies federal rules to allow individuals receiving unemployment benefits to start self-employment businesses without first exhausting their regular benefits. It requires that these self-employment activities include approved entrepreneurial training, business counseling, or a submitted business plan with a market feasibility study. The changes take effect two years after enactment, though states are permitted to adopt similar rules earlier. The Department of Labor will issue regulations and guidance to help state agencies implement these new requirements.
The Saving Today's Acute-Care Resources Act modifies how Medicare calculates payment rates for long-term care hospitals to ensure they receive appropriate funding for treating complex patients. Starting in fiscal year 2027, the bill expands the criteria for avoiding payment reductions by adding a "high acuity" standard that considers patients transferred from acute care or critical access hospitals with severe diagnoses. It also updates existing rules to include discharges from long-term care hospitals that have undergone significant construction projects or hold state certificates of need. These changes aim to adjust reimbursement levels based on the severity of patient conditions and the specific history of the hospital treating them.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.
